THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE.
Heliospectra AB (publ) (”Heliospectra” or the “Company”) has prepared an information document (the “Information Document”) with respect to the rights issue of shares resolved by the Board of Directors on 29 September 2025 (the “Rights Issue”), conditional on the subsequent approval by the general meeting, which was given on 30 October 2025 and was announced the same day. The Information Document is available on the Company’s website, www.heliospectra.com. The Information Document will also be made available on Aqurat Fondkommission AB’s website, www.aqurat.se.
On 29 September 2025, the Board of Directors of the Company resolved, conditional on the subsequent approval by the general meeting, to carry out an issue of new shares up to approximately SEK 49.5 million with preferential rights for existing shareholders. On 30 October 2025, the extraordinary general meeting resolved to approve the Board of Directors’ resolution regarding the Rights Issue. Complete information, terms and instructions regarding the Rights Issue can be found in the Information Document. The Information Document is available on Heliospectra’s website, www.heliospectra.com, and will also be made available on Aqurat Fondkommission AB’s website, www.aqurat.se.
The Information Document
With respect to the Rights Issue, the Company has prepared the Information Document in accordance with article 1.4 db) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, as amended (the “Prospectus Regulation“). The Information Document contains the information specified in Annex IX of the Prospectus Regulation. The Information Document has been registered with the Swedish Financial Supervisory Authority (the “SFSA”), however, the SFSA has not reviewed or approved the Information Document. Each investor is encouraged to make their own assessment of whether it is appropriate to invest in the Company.
Indicative time plan for the Rights Issue
The time plan below for the Rights Issue is preliminary and may be subject to change.
| Trading in subscription rights | 5 – 14 November 2025 |
| Subscription period | 5 – 19 November 2025 |
| Trading in paid subscribed shares (BTA) | 5 November – 1 December 2025 |
| Announcement of outcome of the Rights Issue | 21 November 2025 |
Advisers
MAQS Advokatbyrå AB is legal adviser to the Company in connection with the Rights Issue and Aqurat Fondkommission AB acts as issuing agent.

